Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Sales (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Return on Sales data on record, last reported at 2.25% in Q4 2025.

  • For Q4 2025, Return on Sales rose 218.0% year-over-year to 2.25%; the TTM value through Dec 2025 reached 0.78%, up 77.0%, while the annual FY2025 figure was 0.17%, 16.0% up from the prior year.
  • Return on Sales reached 2.25% in Q4 2025 per INDV's latest filing, up from 0.13% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.25% in Q4 2025 and bottomed at 0.33% in Q2 2024.